Can you fight? Is it enough? How many have been vaccinated?
Multiple departments respond to the latest vaccination situation of the new crown vaccine
Xinhua News Agency reporters Peng Yunjia, Wei Yukun, Zhang Xinxin, Wang Linlin, Mu Tiecheng
"As of March 14, my country has received 64.98 million doses of the new crown virus vaccine." Li Bin, deputy director of the National Health Commission, said that at present, my country is organizing and implementing vaccination in accordance with the principle of sequential advancement of key populations, high-risk groups and other groups. , Steadily increase the population coverage of the new coronavirus vaccine.
Why vaccinate against the new coronavirus?
How about the vaccine production?
How to ensure the quality and safety of vaccines?
At the press conference of the State Council Information Office held on the 15th, relevant persons in charge of multiple departments responded.
Vaccination is the best way to prevent new coronary pneumonia
"The best way to prevent new coronary pneumonia is to vaccinate." Li Bin said at the press conference that although the epidemic situation in my country is generally stable, there is still the risk of epidemic import and local epidemics. Vaccination can reduce the infection rate, severe disease rate and death. This is also the most important strategy for my country’s current prevention and control of the new crown pneumonia epidemic.
He said that the more people who are vaccinated, the more people who have immunity, so that the spread of the new coronavirus in the population can be effectively controlled, which not only protects themselves and their families, but also protects others. .
"The formation of a herd immune barrier against the new coronavirus is related to the effectiveness of vaccine protection and population coverage." said Wang Huaqing, chief expert of the China Centers for Disease Control and Prevention's immunization program. In the past, smallpox was eliminated to form a population immunity of about 85%. People with immunity account for 85% of the entire population.
Wang Huaqing said that the final vaccination of all eligible members of the public is the basis for the establishment of an immune barrier or herd immunity, and it also requires efforts from all aspects.
"Currently, inoculation work in various regions is mainly based on the target population, and mainly depends on the organization of the unit to organize centralized vaccination." Chang Jile, director of the National Health Commission's Disease Control Bureau, said that in places where the target population is concentrated, some temporary vaccination points have also been added in various regions.
He reminded that the public can consult the local health administrative department, disease control agency, and vaccination unit through online or telephone consultation.
What is the productivity of the new coronavirus vaccine?
Tian Yulong, chief engineer of the Ministry of Industry and Information Technology, said that at present, 4 vaccines produced by Sinopharm Zhongsheng Beijing Company, Sinopharm Zhongsheng Wuhan Company, Beijing Kexing Zhongwei Company, and Tianjin Kangsino Company's adenovirus vector vaccines have been qualified. Listing approval.
"We have established a dynamic guarantee balance mechanism for production supply and demand, accurately measure the inoculation demand, implement step by step, and achieve precise docking." He said that with the continuous release of production capacity, the output will gradually increase, and we are confident to meet the needs of all stages. .
A stable and adequate supply of materials is an important task to ensure vaccine production.
Tian Yulong said that the Ministry of Industry and Information Technology has focused on the production, procurement, and supply of materials. Now the supply of raw materials for vaccine production is orderly, stable, and sufficient, which can meet the needs of large-scale production at present and in the future.
After the vaccine is produced, it is essential that it be delivered safely, efficiently and quickly to the vaccination and distribution points.
Tian Yulong said that the Ministry of Industry and Information Technology and relevant departments have established an efficient docking mechanism to ensure that vaccine production, transportation, and supply are guaranteed.
In terms of vaccine circulation and use safety management, Li Bin said that the country has established a national vaccine electronic traceability collaboration platform to ensure that vaccines can be traced throughout the entire process, and the source and whereabouts of vaccines can be traced.
Disease control agencies and inoculation units strictly control the entry and exit of vaccines, and regularly monitor and record the temperature of the new coronavirus vaccine during storage and transportation to ensure the safety of storage and transportation.
How to ensure the safety of the new coronavirus vaccine?
"my country has established a relatively complete vaccine regulatory system, a relatively complete legal system and a vaccine quality standard system." said Yuan Lin, director of the Department of Drug Control of the State Drug Administration, and the implementation is in line with the international advanced level. Good pharmaceutical production quality management practices.
Yuan Lin introduced that vaccine manufacturers are the first person responsible for quality and safety. They must fully implement their main responsibilities in accordance with the law, strictly implement the management standards for drug production quality, and organize production in strict accordance with the state-approved production process and standards.
"For the four companies that have been conditionally approved for listing, we have organized a comprehensive and systematic inspection of the companies in the first time." Yuan Lin said that in order to further ensure the quality and safety of vaccines, companies are strictly required to perform all the inspections of the factory in accordance with legal obligations. And assume the responsibility for release on the market, promptly and actively collect and analyze abnormal reactions that occur during vaccination, to ensure the safety of the entire chain and controllable quality.
Vaccines are varieties that require strict supervision and must pass batch issuance inspections to maintain vaccine quality and safety. This is also an internationally accepted effective regulatory measure and powerful means for biological products or vaccines.
Yuan Lin said that at present, including national drug inspection agencies, provincial drug inspection agencies such as Beijing, Hubei, and Guangdong are fully equipped with the ability to inspect and batch issue new coronavirus vaccines. It is expected that there will be more than a dozen provincial inspections in the near future. Institutions have successively been equipped with vaccine inspection and batch issuance capabilities.
Yuan Lin said that in order to actively cooperate with the continuous expansion of my country's new crown vaccine production capacity, under the premise of ensuring quality, the inspection by inspection agencies and the company's legal self-inspection were started, carried out and completed simultaneously, which greatly shortened the market cycle of new crown virus vaccines. .